Both Ozempic and Wegovy are semaglutide injections
Specific situations warrant urgent professional dietary consultation: Unintentional excessive weight loss losing more than 1 kg weekly consistently, or experiencing rapid weight loss that feels uncontrolled Inability to meet minimum calorie requirements due to severe appetite suppression, nausea, or other side effects Signs of nutritional deficiency , including unusual fatigue, weakness, hair loss, brittle nails, frequent infections, or poor wound healing Pre-existing eating disorders or disordered eating patterns, as GLP-1 medications may complicate these conditions Complex medical conditions such as chronic kidney disease, liver disease, or malabsorption disorders requiring specialised dietary management Pregnancy or breastfeeding GLP-1 medications should not be used during pregnancy
Never place it in your checked baggage, as the aircraft hold can expose it to freezing temperatures that could damage the medication
Retatrutide is an investigational GIP/GLP-1 glucagon triple hormone receptor agonist developed by Eli Lilly and Company
Accumulating evidence has verified that perturbation of Gln metabolism can significantly affect TCA cycle flux and tumor cell proliferation [48,49,50]